The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proposal of a coagulation score to predict postoperative survival of patients undergoing neoadjuvant therapy followed by subtotal esophagectomy for squamous cell carcinoma of the esophagus.
 
Fumitake Sugiyama
No Relationships to Disclose
 
Dai Shimizu
No Relationships to Disclose
 
Mitsuro Kanda
No Relationships to Disclose
 
Chie Tanaka
No Relationships to Disclose
 
Hideki Takami
No Relationships to Disclose
 
Yoshikuni Inokawa
No Relationships to Disclose
 
Norifumi Hattori
No Relationships to Disclose
 
Masamichi Hayashi
No Relationships to Disclose
 
Goro Nakayama
No Relationships to Disclose
 
Michitaka Fujiwara
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Abbvie; Amgen; Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Lilly Japan; Miyarisan Pharmaceutical; MSD K.K; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Consulting or Advisory Role - Daii Sankyo
Research Funding - abbott Japan (Inst); Bayer (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Otsuka (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); TOA Pharmaceuticals (Inst); Tsumura & Co. (Inst)